Bruker (NASDAQ:BRKR – Free Report) had its price target decreased by Citigroup from $75.00 to $50.00 in a research note published on Monday morning,Benzinga reports. Citigroup currently has a buy ...

Discover how Bruker’s BRAVO handheld Raman spectrometer is transforming material analysis with advanced fluorescence suppression and more.

Avicanna Inc. ("Avicanna" or the "Company) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to ...

The 'Multi-Talent' uses standard 5 mm NMR samples, includes gradient spectroscopy, with options for adjustable sample ...

The Financial Times has named Dr. Phone Fix Canada Corporation ("Dr. Phone Fix" or "Company") to its list of 'The Americas' ...

At the Joint ENC-ISMAR Conference 2025, Bruker Corporation announced the launch of a Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configur ...

ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, ...

Citi lowered the firm’s price target on Bruker (BRKR) to $50 from $75 and keeps a Buy rating on the shares as part of a Q1 preview for the life ...

California Public Employees Retirement System cut its stake in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 9.8% in ...